5th Annual Stem Cell Summit

New York city, United States (February 16, 2010)

No company, surgeon or industry analyst can afford to miss this meeting. With more than 50 presentations by the stem cell therapy commercial and technology leaders, this is the most critical stem cell meeting of the year. Featuring:

• 6 major new stem cell therapies, all forecast to reach physicians and surgeon practitioners in 2010• New allograft products, new forms of autologous stem cell technologies, and at least one FDA approved stem cell drug• Major new studies showing rehydration of the disc nucleus, new heart muscle regeneration studies, and others• 35 corporate presenters• 300 attendees expected• Unparalleled networking opportunities• Presentations will include the description of a dramatic new source of stem cells―placental tissues• Scientific panels, individual tracks for stem cells tools & instruments, and your personal copy of the annual Stem Cell Market Analysis & Forecast (2009-2019) containing profiles of the world’s top 50 stem cell companies• And, of course, Robin Young’s updated 10-year forecast for the industry

More: http://www.stemcellsummit.com/